Anaplastic Thyroid Cancer

Also known as: Thyroid Cancer, Anaplastic / Cancer, Anaplastic Thyroid / Anaplastic Thyroid Cancers / Anaplastic thyroid carcinoma (disorder) / Thyroid Carcinoma, Anaplastic

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB01229	Paclitaxel	0	Active Not Recruiting	1
DB08911	Trametinib	0	Active Not Recruiting	1
DB17350	AIC100	1	Recruiting	1
DB00051	Adalimumab	1	Withdrawn	1
DB00958	Carboplatin	1	Completed	1
DB15631	Edodekin alfa	1	Completed	1
DB15721	Natural Killer Cell	1	Completed	1
DB01229	Paclitaxel	1	Completed	1
DB00072	Trastuzumab	1	Completed	1
DB00515	Cisplatin	1 / 2	Completed	1
DB12925	Crolibulin	1 / 2	Completed	1
DB05189	EPC2407	1 / 2	Completed	1
DB01229	Paclitaxel	1 / 2	Terminated	1
DB14892	Spartalizumab	1 / 2	Completed	1
DB15106	Surufatinib	1 / 2	Active Not Recruiting	1
DB14922	Tislelizumab	1 / 2	Active Not Recruiting	1
DB12001	Abemaciclib	2	Active Not Recruiting	1
DB11595	Atezolizumab	2	Active Not Recruiting	1
DB08875	Cabozantinib	2	Active Not Recruiting	1
DB08912	Dabrafenib	2	Recruiting	2
DB11894	Efatutazone	2	Completed	1
DB09078	Lenvatinib	2	Completed	1
DB09078	Lenvatinib	2	Recruiting	1
DB09035	Nivolumab	2	Recruiting	1
DB01229	Paclitaxel	2	Completed	1
DB09037	Pembrolizumab	2	Completed	1
DB17552	Pucotenlimab	2	Not Yet Recruiting	1
DB11836	Sapanisertib	2	Active Not Recruiting	1
DB00398	Sorafenib	2	Terminated	2
DB00398	Sorafenib	2	Unknown Status	1
DB08911	Trametinib	2	Recruiting	2
DB00958	Carboplatin	2 / 3	Terminated	1
DB12596	Combretastatin	2 / 3	Terminated	1
DB12577	Fosbretabulin	2 / 3	Terminated	1
DB01229	Paclitaxel	2 / 3	Terminated	1
DB00958	Carboplatin	3	Withdrawn	1
DB12596	Combretastatin	3	Withdrawn	1
DB12577	Fosbretabulin	3	Withdrawn	1
DB01229	Paclitaxel	3	Withdrawn	1
DB00317	Gefitinib	Not Available	Completed	1